The Board of Directors of foremost pharmaceutical company, GlaxoSmithKline Consumer Nigeria Plc (GSK), has appointed a new Managing Director (MD). The announcement was made recently at the 48th Annual General Meeting of the company.
The new Managing Director, whose appointment took effect from 1st June, 2019, is Mr Kunle Oyelana.
A pharmacist by training, Oyelana brings to the Board of GlaxoSmithKline 20 years wealth of experience in the pharmaceutical industry. 14 years of those years was spent in managerial positions spanning Africa and Asia.
Before rising to the rank of MD, he was the Marketing Director of the company, for the Classic and Established Products (CEP) portfolio in Africa and developing countries in Asia.
Mr Oyelana’s educational background: He is an alumnus of Obafemi Awolowo University, Ile Ife, where he bagged a Bachelor’s in Pharmacy. He equally holds a Master’s of Business Adminstration (MBA) degree from the same institution.
Core competences: His areas of core competence encompass sales, marketing and business development in pharmaceuticals, vaccines and consumer healthcare.Oyelana rose to the position of Group Product Manager for Vaccines in Anglophone & Francophone West Central Africa in July 2007. He served in this capacity between January 2005 and June 2007.
Other positions held: In January 2009, he left the position of Group Product Manager to take up the role of Sales Manager, Vaccines between February 2009 and May 2009.
After this, Oyelana served as the Group Product Manager, Antibiotics for Nigeria and Anglophone West Africa from June 2009 to June 2010.He was made Category Manager of GSK Africa Centre of Excellence for Classic Brands in July 2010, a position he left in March 2012.
Also, Mr Oyelana spent over 3 years as Marketing Manager for Nigeria and Anglophone West Africa between April 2012 and September 2015, after which he was appointed the Marketing Director of GSK in September 2015.
Remark after appointment: After he was appointed the Managing Director of the company, Oyelana remarked, “I am excited at this new opportunity and I’m confident about the outlook for the GSK business in Nigeria. Together, with the resilience of the Nigerian team, we hope to continue to serve our customers, grow our brands and contribute to the economic growth of Nigeria.
Given the exceptional talents that we have in Nigeria and the huge resource base of the country, I am confident that GSK will continue to deliver immense value to our consumers.”